The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma

International Journal of Oncology

Volumn 42, Issue 6, 2013, Pages 1858-1868

  Jikuzono, Tomoo ^a   Kawamoto, Masashi ^b   Yoshitake, Hiroshi ^a   Kikuchi, Kunio ^a   Akasu, Haruki ^c   Ishikawa, Hitoshi ^d   Hirokawa, Mitsuyoshi ^e   Miyauchi, Akira ^e   Tsuchiya, Shinichi ^b   Shimizu, Kazuo ^a   Takizawa, Toshihiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

^d Yamagata Saisei Hospital   (Japan)

^e KUMA HOSPITAL   (Japan)

Author keywords

Metastasis; MicroRNA; Minimally invasive follicular thyroid carcinoma; Prognostic factor; Thyroid surgery

Indexed keywords

MICRORNA; MICRORNA 10B; MICRORNA 221; MICRORNA 222; MICRORNA 92A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; MALE; METASTASIS POTENTIAL; MINIMALLY INVASIVE FOLLICULAR THYROID CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THYROID CARCINOMA; UPREGULATION;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LASER CAPTURE MICRODISSECTION; MALE; MICRORNAS; MIDDLE AGED; PARAFFIN EMBEDDING; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84876566718     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1879     Document Type: Article

References (53)

1. Vinay K, Abul KA, Nelson F and Richard M: Robbins: Basic Pathology, 8th edition. Saunders, Philadelphia, PA, 2007.
2. LiVolsi VA: Pathology of thyroid disease. In: Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine and Radiotherapy. Falk SA (ed). Lippincott-Raven, Philadelphia, PA, pp127-175, 1997.
3. DeLellis RA and Williams ED: Thyroid and parathyroid tumours. In: World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Endocrine Organs. DeLellis RA, Lloyd RV, Heitz PU and Eng C (eds). IARC Press, Lyon, pp51-56, 2004.
4. Sobrinho-Simoes M, Albores-Saavedra J and Tallini G: Poorly dirrerentiated carcinoma. In: World Health Organization Classifcation of Tumours. Pathology and Genetics. Tumours of Endocrine Organs. DeLellis RA, Lloyd RV, Heitz PU and Eng C (eds). IARC Press, Lyon, pp73-76, 2004.
5. Ito Y, Hirokawa M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K and Miyauchi A: Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination. World J Surg 31: 1417-1424, 2007. (Pubitemid 46945384)
6. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116: 281-297, 2004.
7. Chen CZ: MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353: 1768-1771, 2005.
8. Iorio M V, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo J P, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Neqrini M and Croce CM: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005. (Pubitemid 41161233)
9. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T and Shimotohno K: Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25: 2537-2545, 2005.
10. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio M V, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volnia S, Liu CG, Kipps TJ, Negrini M and Croce CM: A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801, 2005. (Pubitemid 41549891)
11. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM and Harris CC: Unique microRNA molecular profles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006. (Pubitemid 43357945)
12. Kip1 protein levels and cell cycle. Endocr Relat Cancer 14: 791-798, 2007. (Pubitemid 350074067)
13. Pallante P, Visone R, Croce CM and Fusco A: Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas. Endocr Relat Cancer 17: F91-F104, 2010.
14. Mazeh H, Mizrahi I, Halle D, Ilyayev N, Stojadinovic A, Trink B, Mitrani-Rosenbaum S, Roistacher M, Ariel I, Eid A, Freund HR and Nissan A: Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples. Thyroid 21: 111-118, 2011.
15. Hair JF Jr, Anderson RE, Tatham RL and Black WC: Multivariate Data Analysis with Readings. 4th edition. Prentice-Hall, Englewood Cliffs, 1995.
16. Cohen J, Cohen P, West SG and Aiken LS: Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. 3rd edition. Lawrence Erlbaum Associates, Mahwah, NJ, 2003.
17. Guthrie JL, Seah C, Brown S, Tang P, Jamieson F and Drews SJ: Use of Bordetella pertussis BP3385 to establish a cutoff value for an IS481-targeted real-time PCR assay. J Clin Microbiol 46: 3798-3799, 2008.
18. Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K and Ju J: Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fxed paraffn-embedded samples. RNA 13: 1668-1674, 2007. (Pubitemid 47481675)
19. Cronin M, Pho M, Dutta D, Stephans JC, Shak S, Kiefer MC, Esteban JM and Baker JB: Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am J Pathol 164: 35-42, 2004. (Pubitemid 38364587)
20. Masuda N, Ohnishi T, Kawamoto S, Monden M and Okubo K: Analysis of chemical modifcation of RNA from formalin-fxed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res 27: 4436-4443, 1999. (Pubitemid 29533185)
21. Srinivasan M, Sedmak D and Jewell S: Effect of fxatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 161: 1961-1971, 2002. (Pubitemid 35434840)
22. Nikiforova MN, Tseng GC, Steward D, Diorio D and Nikiforov YE: MicroRNA expression profling of thyroid tumors: biological signifcance and diagnostic utility. J Clin Endocrinol Metab 93: 1600-1608, 2008. (Pubitemid 351656494)
23. Takano T, Miyauchi A, Yoshida H, Kuma k and Amino N: High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas: Br J Cancer 90: 1600-1605, 2004. (Pubitemid 38648245)
24. Foukakis T, Gusnanto A, Au AY, Höög A, Lui WO, Larsson C, Wallin G and Zedenius J: A PCR-based expression signature of malignancy in follicular thyroid tumors: Endocr Relat Cancer 14: 381-391, 2007.
25. Lu J, Getz G, Miska EA, Alvarz-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR and Golub TR: MicroRNA expression profles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
26. K ip1. J Biol Chem 282: 23716-23724, 2007. (Pubitemid 47311902)
27. Kip1. J Biol Chem 283: 29897-29903, 2008.
28. Zhang C, Han L, Zhag A, Yang W, Zhou X, Pu P, Du Y, Zeng H and Kang C: Global changes of mRNA expression reveals an increased activity of the interferon-induced signal transducer and activator of transcription (STAT) pathway by repression of miR-221/222 in glioblastoma U251 cells. Int J Oncol 36: 1503-1512, 2010.
29. Le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A, Anile C, Maira G, Mercatelli N, Ciafre SA, Farace MG and Agami R: Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26: 3699-3708, 2007. (Pubitemid 47236875)
30. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbiori S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L and Negrini M: MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27: 5651-5661, 2008.
31. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM and de la Chapelle A: The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080, 2005. (Pubitemid 43049568)
32. Ma L, Teruya-Feldstein J and Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688, 2007. (Pubitemid 47552092)
33. Tan HX, Wang Q, Chen LZ, Huang XH, Chen JS, Fu XH, Cao LQ, Chen XL, Li W and Zhang LJ: MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med Oncol 27: 654-660, 2010.
34. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C and Croce CM: MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297: 1901-1908, 2007. (Pubitemid 46707844)
35. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG: Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351-1358, 2005. (Pubitemid 41074723)
36. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T and Holland EC: The PTEN-regulating microRNA miR-26a is amplifed in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 23: 1327-1337, 2009.
37. Sun L, Yan W, Wang Y, Sun G, Luo H, Zhang J, Wang X, You Y, Yang Z and Liu N: MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res 1389: 9-18, 2011.
38. Ma L and Weinberg RA: Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet 24: 448-456, 2008.
39. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S, Yoshida Y and Seto M: Identifcation and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplifcation in malignant lymphoma. Cancer Res 64: 3087-3095, 2004. (Pubitemid 38581408)
40. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y and Takahashi T: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632, 2005. (Pubitemid 41541436)
41. Monzo M, Navarro A, Bandres E, Artells R, Moreno I, Gel B, Ibeas R, Moreno J, Martinez F, Diaz T, Martinez A, Balagué O and Garcia-Foncillas J: Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res 18: 823-833, 2008.
42. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, Mongera S, Postma C, Meijerink W J, Carvalho B and Meijer GA: MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 101: 707-714, 2009.
43. Connolly E, Melegari M, Landgraf P, Tchai kovskaya T, Tennant BC, Slagle BL, Rogler LE, Zavolan M, Tuschl T and Rogler CE: Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 173: 856-864, 2008.
44. Chen HC, Chen GH, Chen Y H, Liao WL, Liu CY, Chang KP, Chang YS and Chen SJ: MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer 100: 1002-1011, 2009.
45. Takakura S, Mitsutake N, Nakashima M, Namba H, Saenko VA, Rogounovitch TI, Nakazawa Y, Hayashi T, Ohtsuru A and Yamashita S: Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Sci 99: 147-154, 2008.
46. Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z, Sun J, Tan FW, Ding DP, Xu XH, Zhou F, Tan XG, Hang J, Shi SS, Feng XL and He J: microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J Biol Chem 25: 10725-10734, 2011.
47. Mete O and Asa SL: Pathological defnition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol 24: 1545-1552, 2011.
48. Asari R, Koperek O, Scheuba C, Riss P, Kaserer K, Hoffmann M and Niederle B: Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Ann Surg 249: 1023-1031, 2009.
49. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Kameyama K and Ito K: Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid 21: 751-757, 2011.
50. Mazzaferri EL and Jhiang SM: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97: 418-428, 1994. (Pubitemid 24345593)
51. van Heerden JA, Hay ID, Goellner JR, Salomao D, Ebersold JR, Bergstralh EJ and Grant CS: Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery 112: 1130-1138, 1992. (Pubitemid 23008242)
52. Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF and Heffess CS: A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer 91: 505-524, 2001. (Pubitemid 32105696)
53. Mazafferi EL and Kloos RT: Carcinoma of follicular epithelium: radioiodine and other treatments and outcomes. In: The Thyroid. Braverman LE and Utiger RD (eds). Lippincott Williams & Wilkins, Philadelphia, PA, pp934-966, 2005.